Joaquim C. S. Limaa, Ruberlei Godinho de Oliveiraa, Virgínia C. Silvab, Paulo Teixeira de Sousa Jrb , Ivana M. P. Violanteac , Antonio Machoa & Domingos Tabajara de Oliveira Martinsa* a Área de Farmacologia, Departamento de Ciências Básicas em Saúde, Faculdade de Medicina, Universidade Federal de Mato Grosso, Cuiabá, Brazil; b Departamento de Química, Instituto de Ciências Exatas e da Terra, Universidade Federal de Mato Grosso, Cuiabá, Brazil; c Departamento de Farmácia, Universidade de Cuiabá, Cuiabá, BrazilSupplemental data for this article can be accessed at https://doi.org/10.1080/14786419.2018.1495636CONTACT Domingos Tabajara Oliveira Martins taba@terra.com.brAbstractFridericia chica, Bignoniaceae, is a tropical tree-creeper used as a traditional remedy for a number of diseases, highlighting inflammation. Our objective was to corroborate the popular anti-inflammatory use of the hydroethanolic extract from the leaves (HEFc) and of its isolated 4′,6,7-trihydroxy-5-methoxyflavone (5-O-methylscutellarein) [1], described here for the first time. Quantitative analysis indicated 8.77 ± 0.23 mg/g of this compound in the extract. Neither HEFc nor [1] was cytotoxic in vitro. In LPS-induced peritonitis in mice, oral pre-treatment with HEFc or [1] led to decreased leukocyte migration to the peritoneal cavity and a reduction in the concentrations of pro-inflammatory cytokines (TNFα and IL-1β). Also, the anti-inflammatory cytokine IL-10 was enhanced following treatment with [1]. Overall, these results validate the traditional use of Fridericia chica as anti-inflammatory, and indicate that the compound 5-O-methylscutellarein may participate in this effect.
No takes yet. Share an insight, caveat, or question.
Lima et al. (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: